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LETTERS TO THE EDITOR
A Novel Point Mutation in the Keratin 17 Gene in a Japanese
Case of Pachyonychia Congenita Type 2
To the Editor:
Pachyonychia congenita type 2 (PC-2; MIM#167210), also known
as Jackson-Lawler type (Jackson and Lawler, 1951), is a rare
autosomal dominantly inherited disease characterized by hyper-
trophic nail dystrophy, focal keratoderma, multiple pilosebaceous
cysts, natal teeth, and hair abnormalities (McKusick, 2001).
Heterozygous missense mutations of the keratin 17 (K17) gene
have been identi®ed in PC-2 (McLean et al, 1995). A mutation in
the keratin 6b gene, which encodes K6b, the expression partner of
K17, has also been reported in PC-2 (Smith et al, 1998). By
sequencing genomic DNA from our PC-2 patient, we found a
novel heterozygous mutation (G®A transition at nucleotide 452,
452G>A) in the helix initiation motif of the K17 gene resulting in a
predicted substitution of valine (GTG) for methionine (ATG) at
codon 102, V102M.
A 19-y-old Japanese man visited our university clinic in March
2000. All of his nails had become thick 2 mo after birth. He had
multiple normally colored papules and cysts on his scalp and axilla
since he was 5 y old, and had hyperkeratosis with blister formation
on his soles since he was 10 y old. At 16, the cysts on his scalp and
axilla became painful and were repeatedly infected. His father,
mother, and younger brother are healthy.
Physical examination showed that he had many cysts and nodules
all over his body, pachyonychia on all his ®ngers and toes, pili torti
(twisted hair), and plantar hyperkeratosis with bullae. His eyebrows
stand erect (Fig 1A). His mouth, tongue, and teeth were normal.
Histologic examination of a subcutaneous cyst showed that the cyst
wall was composed of several layers of epithelial cells accompanied
by sebaceous gland lobules. Therefore, a diagnosis of steatocystoma
was made.
After informed consent, genomic DNA was extracted from a
sample of his peripheral blood lymphocytes by a standard method
(Qiagen, Hilden, Germany). Genomic DNA from 50 normal
healthy Japanese people was used as a control. Exon 1 of the K17
gene was ampli®ed by polymerase chain reaction (PCR) with
speci®c primers for the K17 gene as described previously (McLean
et al, 1995). Nested PCR was initially performed using primers
K17p8 (5¢-GCC TAT AAA GGA AGC GGG C-3¢) and K17p10
(5¢-CTC CTT TCT GCC TCC TCC T-3¢) and then primers
K17p3 (5¢-TAT GGC AGC AGC TTT GGG-3¢) and K17p4 (5¢-
GGT ACC AGT CAC GGA TCT TCA-3¢). Ampli®cation
conditions were 95°C for 1 min, followed by 35 cycles of 95°C for
40 s, 58°C for 40 s, and 72°C for 1 min, and a ®nal extension at
72°C for 3 min. PCR products (157 bp) were puri®ed using a QIA
quick PCR puri®cation kit (Qiagen), and were sequenced on an
Applied Biosystem 310 automated sequencer using an ABI PRISM
¯uorescent dye terminator system (Perkin Elmer, Foster City, CA).
Direct sequencing of DNA from the patient revealed a point
mutation, 452G>A. This transition results in the substitution of a
valine for a methionine (V102M). Another sequence change was
found (T®C transition at nucleotide 457, 457T>C) but this
transition does not change the predicted amino acid. To con®rm
whether these two mutations exist on one allele simultaneously, we
subcloned the PCR products into the pCR2.1-TOPO TA-cloning
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Figure 1. Pedigree, haplotype, and detection of a K17 gene
mutation in a family with PC-2. (A) Photograph of the patient's
upright eyebrows (left eyebrow). (B) Pedigree of the patient's family
with haplotypes for 10 genetic markers on chromosome 17. Analyses of
the haplotypes and sequences are shown below the corresponding
symbols in the pedigree. Black symbol represents the patient. The
marker alleles are shown in base pairs. The patient has a heterozygous
missense mutation at nucleotide 452 (452G>A) resulting in V102M and
a sequence change at nucleotide 457 resulting in R103R. These two
nucleotide changes were detected in a mutant allele by sequencing ®ve
of 12 clones. The other seven clones had normal sequences. His father
and mother had no mutations.
vector (Invitrogen, Carlsbad, CA) and sequenced them. Five clones
out of 12 were mutants, and the two nucleotide changes were on
the mutant allele (Fig 1B). The mutations 452G>A and 457T>C
were on the same allele. These mutations were not detected in the
genomic DNA from his parents (Fig 1B). Because the sequence
change, 457T>C, created an HhaI restriction enzyme site in the
mutant allele, we could distinguish a mutant allele (104 and 53 bp,
or 106 and 51 bp fragments) from a normal allele (157 bp) by HhaI
digestion of the 157 bp PCR products. The patient had both
mutant and normal alleles, whereas his father and mother and the
50 controls had only the normal allele (data not shown). In
addition, by direct sequencing we con®rmed that the 452G>A
mutation was not present in 50 normal Japanese individuals (data
not shown). To exclude the possibility of nonpaternity, we did
microsatellite analysis using 10 genetic markers on chromosome 17
(Fig 1B). The keratin 17 gene is located on chromosome 17
between D17S1299 and D17S809. Ampli®cation conditions were
95°C for 5 min, followed by 35 cycles of 95°C for 1 min, 55°C,
57°C, or 58°C for 1 min, and 72°C for 2 min, and a ®nal extension
at 72°C for 5 min. PCR products were analyzed on Gene Scan 3.1
using an ABI PRISM ¯uorescent dye terminator system (Perkin
Elmer). The analysis of haplotypes showed that the patient was
descended from his parents, suggesting that he had the de novo
mutations as a heterozygote (Fig 1B).
Keratins are heterodimeric proteins that form the intermediate
®lament cytoskelton of epithelial cells. They are expressed in
speci®c epithelial tissues as speci®c type I/type II keratin pairs. Most
of the pathogenic mutations in human keratin diseases occur in the
helix initiation or termination motifs. The K17 type I keratin,
which has a tissue-speci®c and differentiation-speci®c expression
pattern, is expressed in the nail bed, hair follicle, and sebaceous
gland (Troyanovsky et al, 1989; Pantelevey et al, 1997; Smith et al,
1998; McGowan and Coulombe, 2000). We identi®ed a novel
missense mutation (V102M) in the 1A domain of K17 in a Japanese
patient with PC-2. To date, 10 mutations in K17 have been
described in 16 families with either PC-2 or steatocystoma
multiplex (McLean et al, 1995; Covello et al, 1998; Fujimoto et
al, 1998; Celebi et al, 1999; Smith et al, 1997, 2001). All of them
were heterozygous missense mutations in the helix initiation 1A
domain of K17 (Fig 2). This area is highly conserved and even
subtle amino acid changes are thought to disrupt intermediate
®lament formation and assembly. A 423A>G mutation was found
in six families, and a 428C>T mutation in two families. Of the 16
families, six were sporadic cases like ours, in which all of the point
mutations occurred at nucleotide 423. In our case, two de novo
sequence changes occurred at nucleotides 452 and 457 simultan-
eously. This probably happened during gametogenesis or before
pronuclear fusion in the zygote, because the parents had no
mutations in their somatic cells. This region of nucleotides may be
fragile and easily damaged by some environmental factors.
It is of interest that the site of expression of the K17 gene and the
clinical phenotype of PC-2 are highly associated. In the murine hair
follicle, K17 protein is expressed not only in the outer root sheath
but also with polarity in a certain part of the matrix (McGowan and
Coulombe, 2000). It was suggested that disruption of its
polarization in the matrix of the hair follicle alters the orientation
of the hair follicle against the skin surface (McGowan and
Coulombe, 2000), resulting in the upright eyebrows found in
our patient (Fig 1A). Localization of abnormal K17 in the medulla
of hair, nail matrix, and the luminal cell layers of sebaceous glands
(the sebaceous duct epithelium) may cause twisted coarse hair,
thick and hypertrophic nail deformity, and multiple dermal cysts
with sebaceous lobules. Thus, abnormal K17 may lead to
hyperproliferation rather than differentiation. Although the changes
in the three-dimensional structure and the function of abnormal
K17 protein produced by point mutations, especially within the
helix initiation motif, are unknown, it is possible that K17 plays an
important role in the morphology and maintenance of nails, facial
hair, and pilo-sebaceous glands. Further study of the overexpression
and/or disruption of the K17 gene will facilitate our understanding
of the precise function of the K17 protein.
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Figure 2. Schema of K17 protein structure and summary of reported K17 gene mutations in PC-2. Keratin has helix domains (1A, 1B, 2A,
2B) separated by linker domains (L1, L12, L2). The DNA and deduced amino acid sequence of the 1A domain are shown. Mutations in 16 cases of
pachyonychia congenita type 2 and steatocystoma multiplex described previously are shown. All mutations were detected in one family, N92S mutation
indicated by an asterisk in six cases, and R94C indicated by # in two families. Single-letter abbreviations for the amino acid residues: A, Ala; C, Cys;
D, Asp; H, His; K, Lys; L, Leu; M, Met; N, Asn; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val.Y, Tyr.
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EB Simplex Super®cialis Resulting from a Mutation in the
Type VII Collagen Gene
To the Editor:
Epidermolysis bullosa simplex (EBS) is an inherited blistering
disease characterized by intraepidermal cleavage (Gedde-Dahl and
Anton-Lamprecht, 1990; Fine et al, 1991). A very rare subset of
EBS, termed ``EBS super®cialis'' (EBSS), has been described in two
families by Fine et al (1989). Skin biopsy of these patients shows
clefts of variable size just beneath the level of the stratum corneum,
which can be completely separated from the rest of the epidermis in
some cases. In two of the patients reported, there are also some
clefts in the lower one-third of the epidermis.
Together with this unusual clinical picture, most of the patients
show atrophic scarring, milia, nail dystrophy, and blistering
involving the oral cavity. After the ®rst description of EBSS in
two unrelated families, no other cases have been reported,
emphasizing the rareness of these ®ndings.
Up to now, mutations in the genes KRT5, KRT14, and
PLEC1 have been described underlying different subsets of
EBS. None of them, however, is a good candidate for the
super®cial lesions observed in EBSS. KRT5 and KRT14 are
expressed in basal keratinocytes, whereas mutations in the
PLEC1 gene are associated with EBS together with muscular
dystrophy (Smith et al, 1996). In the absence of a candidate
gene for EBSS, we performed a genome-wide screen in one of
the pedigrees previously described (Fine et al, 1989). The
second family was not included in the study, as only the
proband showed evidence of blister formation, suggesting a
sporadic mutation. Brie¯y, the affected individuals studied here
belong to a ®ve-generation pedigree with an autosomal
dominant pattern of inheritance (Fig 1a). In affected family
members, variably sized clefts were noted just beneath the level
of the stratum corneum in each biopsy specimen (Fine et al,
1989). In some, clefts were subcorneal; in others, lower
intraepidermal. In none of the affected individuals was sub-
lamina densa cleavage noted, nor was any diminution of type
VII collagen staining noted using the anti-type VII antibody LH
7:2 (Fine et al, 1989).
A genome-wide screen was performed using a panel of 324
microsatellite markers, with an average marker spacing of 10 cM and
a semiautomated ¯uorescence-based genotyping system (Aita et al,
1999). Two-point linkage analyses were carried out using the
MLINK program of the FASTLINK suite of programs (Lathrop et al,
1984; Cottingham et al, 1993; Schaffer et al, 1994). A disease allele
frequency of 0.001 and an autosomal dominant mode of inheritance
with complete penetrance were assumed. The marker allele
frequencies were estimated from observed and reconstructed
genotypes of founders within the pedigree. To avoid computation
errors due to observed allele frequencies of 0.0, alleles for all markers
were re-coded using the RECODE program (Weeks, 2000).
Multipoint analyses and reconstruction of pedigrees were carried out
using the SIMWALK program version 2.6 (Sobel and Lange, 1996).
The results of the initial genome-wide scan revealed three
chromosomal regions with a maximum two-point LOD score
greater than 1.4, on chromosomes 3 (Zmax = 1.62), 8 (Zmax =
1.80), and 10 (Zmax = 1.40). Haplotype and multipoint analyses of
additional markers allowed us to exclude the regions on chromo-
somes 8 and 10, and to more decisively establish the linkage to
chromosome 3.
A total of 28 additional markers were used for the ®ne-mapping of
the EBSS locus. Maximum two-point LOD scores of 4.11 and 3.77
at q = 0.0 were obtained for markers D3S2420 and D3S3582,
respectively. Multipoint linkage analysis showed a maximum LOD
score of 5.96 for marker D3S2420 (Fig 1b). Finally, analysis of the
reconstructed haplotypes con®rmed the linkage results and placed
the disease locus within a 2.94 cM region on chromosome 3, ¯anked
by markers D3S3624 and D3S1289 (Fig 1a).
According to the different maps derived from the Human
Genome Project (Human Genome Project Working Draft; National
Center for Biotechnology Information; Ensembl Genome Server;
GeneMap'99), the region ¯anked by markers D3S3624 and
D3S1289 spans approximately 10 Mb of genomic DNA on 3p21.
Coincidentally, the COL7A1 gene, in which mutations are
responsible for DEB (Uitto et al, 1999; Fine et al 2000), lies within
this genetic interval. Type VII collagen is the main constituent of the
anchoring ®brils and at the microscopic level, DEB is characterized
by skin cleavage beneath the lamina densa. The morphologic defect
is a reduced number or complete absence of the anchoring ®brils, in
the dominant and recessive forms of DEB, respectively (Tidman and
Eady, 1985). In DEB skin, blisters appear just beneath an intact
lamina densa. In contrast, the family we studied and reported by Fine
et al (1989) showed blister formation just beneath the stratum
corneum. On the basis of the differences in phenotype between
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